Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Second Life Therapeutics
Onchilles Pharma Inc
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.
CHU de Quebec-Universite Laval